Nationwide mortality trends for non-alcoholic fatty liver disease and diabetes mellitus in the U.S. (1999-2022): insights from the CDC WONDER database.

Nationwide mortality trends for non-alcoholic fatty liver disease and diabetes mellitus in the U.S. (1999-2022): insights from the CDC WONDER database.

Publication date: Dec 01, 2026

Non-alcoholic fatty liver disease (NAFLD) and diabetes mellitus (DM) are increasingly prevalent, interrelated conditions contributing significantly to morbidity and mortality. Understanding long-term mortality trends is essential to guide public health strategies. This study aimed to evaluate nationwide mortality trends involving NAFLD and DM in the United States from 1999 to 2022 and to assess demographic and geographic disparities. CDC WONDER was used to extract data for adults aged ≥ 25 years. 10th Revision (ICD-10), using the explicit codes with K74. 0, K74. 6, K75. 8, K76. 0 and K76. 9 for NAFLD and E10-E14 for DM. Age- Adjusted Mortality Rates (AAMRs) per million population were calculated and trends were analyzed by calculating annual percent change (APC) and the average annual percent change (AAPC) using Joinpoint Regression Program (version 5. 2.0. 0; National Cancer Institute), with statistical significance set at p 

Concepts Keywords
CDC WONDER
Diabetes mellitus (DM)
Mortality
Trends

Semantics

Type Source Name
disease MESH non-alcoholic fatty liver disease
pathway KEGG Non-alcoholic fatty liver disease
disease MESH diabetes mellitus
disease MESH ICD
disease MESH APC
disease MESH Cancer

Original Article

(Visited 3 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *